| Alzheimer Disease |
1 |
1 |
| Hypertension |
0 |
0.91 |
| Cerebrovascular Accident |
0 |
0.75 |
| Dementia |
0 |
0.67 |
| Multi-Infarct Dementia |
0 |
0.57 |
| Receptors |
0 |
0.48 |
| Antihypertensive Agents |
0 |
0.42 |
| Heart Failure (HF) |
0 |
0.24 |
| Blood |
0 |
0.23 |
| Arrhythmia |
0 |
0.19 |
| Cardiovascular Risk Management |
0 |
0.18 |
| Myocardial Infarction (MI) |
0 |
0.17 |
| Medicare |
0 |
0.13 |
| Atrial Fibrillation |
0 |
0.12 |
| Brain |
0 |
0.1 |
| Heart |
0 |
0.1 |
| Calcium Channel Blockers |
0 |
0.09 |
| Guidelines for Hypertension |
0 |
0.09 |
| Healthcare and Medical Technology |
0 |
0.08 |
| Osteoarthritis |
0 |
0.08 |
| Beta-Adrenergic Agonist |
0 |
0.06 |
| Calcium |
0 |
0.06 |
| Clinical Guidelines |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Infarction |
0 |
0.06 |
| Revenue and Practice Management |
0 |
0.06 |
| Patient Safety |
0 |
0.04 |
| ACE Inhibitor |
0 |
0.03 |
| Adverse Effects |
0 |
0.03 |
| Calcaneal |
0 |
0.03 |
| Cognition |
0 |
0.03 |
| Diuretics |
0 |
0.03 |
| New York |
0 |
0.03 |
| Prescription Drugs |
0 |
0.03 |
| Salary and Compensation |
0 |
0.03 |
| Washington |
0 |
0.03 |